Biofrontera Ag Stock Return On Equity
Biofrontera AG fundamentals help investors to digest information that contributes to Biofrontera's financial success or failures. It also enables traders to predict the movement of Biofrontera Stock. The fundamental analysis module provides a way to measure Biofrontera's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biofrontera stock.
Biofrontera |
Biofrontera Return On Equity Analysis
Biofrontera's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Biofrontera Return On Equity | -124.08 |
Most of Biofrontera's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biofrontera AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Biofrontera AG has a Return On Equity of -124.08. This is much higher than that of the Healthcare sector and 240.32% higher than that of the Biotechnology industry. The return on equity for all United States stocks is notably higher than that of the company.
Biofrontera Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biofrontera's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biofrontera could also be used in its relative valuation, which is a method of valuing Biofrontera by comparing valuation metrics of similar companies.Biofrontera is currently under evaluation in return on equity category among related companies.
Biofrontera Fundamentals
Return On Equity | -124.08 | |||
Return On Asset | -10.51 | |||
Profit Margin | (55.98) % | |||
Operating Margin | (35.09) % | |||
Current Valuation | 69.38 M | |||
Shares Outstanding | 28.36 M | |||
Shares Owned By Institutions | 3.09 % | |||
Number Of Shares Shorted | 5.49 K | |||
Price To Earning | (24.73) X | |||
Price To Book | 3.51 X | |||
Price To Sales | 2.87 X | |||
Revenue | 27.99 M | |||
Gross Profit | 26.81 M | |||
EBITDA | (4.19 M) | |||
Net Income | (15.67 M) | |||
Cash And Equivalents | 33.7 M | |||
Cash Per Share | 1.19 X | |||
Total Debt | 24.24 M | |||
Debt To Equity | 1.12 % | |||
Current Ratio | 3.93 X | |||
Book Value Per Share | 0.76 X | |||
Cash Flow From Operations | (7.22 M) | |||
Short Ratio | 0.14 X | |||
Earnings Per Share | (0.62) X | |||
Number Of Employees | 149 | |||
Beta | 1.57 | |||
Market Capitalization | 80.19 M | |||
Total Asset | 16.02 M | |||
Retained Earnings | (164.76 M) | |||
Working Capital | 9.53 M | |||
Current Asset | 13.57 M | |||
Current Liabilities | 4.04 M | |||
Z Score | -11.2 |
Pair Trading with Biofrontera
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biofrontera position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofrontera will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Piedmont Lithium could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Piedmont Lithium when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Piedmont Lithium - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Piedmont Lithium to buy it.
The correlation of Piedmont Lithium is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Piedmont Lithium moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Piedmont Lithium moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Piedmont Lithium can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Biofrontera Stock
If you are still planning to invest in Biofrontera AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biofrontera's history and understand the potential risks before investing.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |